Hanger — Investor Presentation (August 2013)
24 slides from Hanger's investor presentation, Aug 21, 2013
Slide 1: 150 Years of Empowering Human Potential - Investor Presentation
150 YEARS Investor Presentation of Empowering Human Potential. August 2013
Slide 2: Safe Harbor
SAFE HARBOR Except for the historical information contained herein, the matters discussed in this presentation constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These include, but are not limited to,
Slide 3: Vision
VISION Be the partner of choice for products and services that enhance human physical capability.
Slide 4: Overview
OVERVIEW • LTM net sales of $1.0 billion • 2012 adjusted EBITDA* of $166 million • 2012 adjusted EPS* of $1.80 • Market capitalization of $1.1 billion • Two segments: – Patient Care – 83% of sales – Products & Services – 17% of sales $760.1 $817.4 $918.5 $985.6 2009 2010 2011 2012 CAGR 9.0%Growth in
Slide 5: Key Investment Points
KEY INVESTMENT POINTS • Compelling O&P industry growth dynamics • Market leader in O&P patient care • Proven organic growth and acquisition capabilities • Solid financial position • Steady margin enhancement • Growth opportunities in adjacent markets
Slide 6: Patient Care Profile
PATIENT CARE • Over 740 O&P patient-care centers in 45 states • Over 1,300 O&P certified and licensed clinicians • Treat more than 1,000,000 patients annually • Stand alone design, fabricate and fit • Delivery through clinics, hospitals and physician offices • Network management capability provides
Slide 7: Patient Care Market Position
PATIENT CARE Hanger 20% MARKET POSITION • Only national or regional provider • No other provider has more than 2% market share $4.3 Billion Total Addressable Market
Slide 8: Consistent Organic and Acquisition Growth
PATIENT CARE 4.9% 4.6% 2.6% 4.0% 3.2% 2.0% 2.8% 4.0% 2009 2010 2011 2012 Same Center Acquisitions/Other 8.1% 6.6% 5.4% 8.0% CONSISTENT ORGANIC AND ACQUISITION GROWTH 5% - 8% Range
Slide 9: Patient Care Reimbursement Sources
PATIENT CARE REIMBURSEMENT SOURCES Commercial and other 59% Medicare 29% Medicaid 6% VA 6% Commercial – 59% • 1-3 year contracts • Scale and capabilities are competitive advantage Government – 41% • O&P is a very small part of trillion dollar healthcare spending • Exempt from MDET and competitive bi
Slide 10: Compelling Growth Drivers
COMPELLING GROWTH DRIVERS • Disease and aging population • Advancing technology • Regulatory and healthcare reform • Increased focus on costs and outcomes 12.4% 12.7% 13.0% 16.1% 19.3% 2000 2008 2010 2020 2030 65+ 2.6% 10.8% 23.1% 20-39 40-59 60+ Sources: Company estimates; Wall Street Research; 200
Slide 11: Patient Care Growth Opportunities
PATIENT CARE • First to market with new technologies and products • Linkia Network Management • Diversification into new adjacent businesses • O&P acquisitions • Sales synergies across businesses • Changing healthcare environment GROWTH OPPORTUNITIES
Slide 12: Products & Services
PRODUCTS & SERVICES
Slide 13: Products & Services Profile
PRODUCT & SERVICES Distribution: • Largest dedicated distributor of O&P devices and components • Over 33,000 O&P related items • 6 strategically located distribution facilities • Manufacture and distribute therapeutic footwear • Development and commercialization of new products Rehabilitative Soluti
Slide 14: Products & Services Opportunities
PRODUCT & SERVICES • Increase value proposition of product line • Increase penetration of existing customer base • Expand market presence geographically • Expand into new channels • Leverage product development and distribution capabilities • Expand O&P fabrication operation to Independent O&P Provi
Slide 15: Financial Overview
FINANCIAL OVERVIEW
Slide 16: Solid Performance and Stability
SOLID PERFORMANCE AND STABILITY • Earnings and margin growth • Substantial cash flow generation • Strong balance sheet management • Moderate leverage • Consistent reduction of leverage
Slide 17: Leveraging Revenue Growth
LEVERAGING REVENUE GROWTH $760.1 $817.4 $918.5 $985.6 2009 2010 2011 2012 CAGR 9.0% ($ in millions) 14.1% 14.8% 16.2% 16.8% Net Sales Adjusted EBITDA Margin* * Reconciliation to GAAP provided on slides 23 and 24
Slide 18: Growth in Adjusted Diluted EPS
GROWTH IN ADJUSTED DILUTED EPS* $1.13 $1.34 $1.57 $1.80 2009 2010 2011 2012 CAGR 16.8% Reconciliation to GAAP provided on slides 23 and 24
Slide 19: Steady Comparable Quarter Growth
STEADY COMPARABLE QUARTER GROWTH $0.10 $0.20 $0.30 $0.40 $0.50 $0.60 Q1 Q2 Q3 Q4 $15 $2 5 $35 $45 $55 Q1 Q2 Q3 Q4 2011 2012 2013 Adjusted EBITDA* ($ in millions) Revenues ($ in millions) Adjusted Earnings Per Diluted Share* $155 $175 $195 $215 $235 $255 $275 Q1 Q2 Q3 Q4 * Reconciliation to GAAP prov
Slide 20: Solid Cash Flow and Balance Sheet
SOLID CASH FLOW AND BALANCE SHEET $53 $72 $54 $62 $81 2008 2009 2010 2011 2012 ACP Acquisition 3.6 2.8 3.3 2.8 3.0 Operating Cash Flow Leverage Ratio* ($ in millions) * Reconciliation to GAAP provided on slides 23 and 24
Slide 21: Key Investment Points
KEY INVESTMENT POINTS • Compelling O&P industry growth dynamics • Market leader in O&P patient care • Proven organic growth and acquisition capabilities • Solid financial position • Steady margin enhancement • Growth opportunities in adjacent markets
Slide 22: Appendix
150 YEARS Appendix of Empowering Human Potential.
Slide 23: Reconciliation of Non-GAAP Financial Measures
RECONCILIATION OF NON- GAAP FINANCIAL MEASURES Dollars in millions, except per share data 2009 2010 2011 2012 Adjusted EBITDA Reconciliation Income from Operations $ 90.5 $ 80.5 $ 116.0 $ 129.3 Depreciation & Amortization $ 16.3 $ 18.8 $ 31.0 $ 34.7 Relocation expenses - $ 16.4 $ 1.2 - Acquisition e
Slide 24: Reconciliation of Non-GAAP Financial Measures (Quarterly)
RECONCILIATION OF NON- GAAP FINANCIAL MEASURES Dollars in millions, except per share data 2011 2012 2013 2013 Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Adjusted EBITDA Reconciliation Income from Operations $ 19.3 $ 32.9 $ 31.2 $ 32.5 $ 116.0 $ 21.7 $ 35.7 $ 35.4 $ 36.5 $ 129.3 $ 22.7 $ 36.6 Depreciation &